Navigation Links
Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
Date:4/20/2010

Interactive event features implementation of MODA-EM™

Wayne, PA (PRWEB) April 20, 2010 -- MODA Technology Partners will offer a live, interactive Webinar on the benefits and value of implementing MODA-EM™, on Tuesday, May 11, 2010 at 11:00 AM ET (8:00 AM PT, 9:00 AM MT). The presentation will feature Marvin Thompson, Manager, Quality Operations at Talecris, and Bob Toal, Vice President at MODA.

Talecris is a global biotherapeutic and biotechnology company that discovers, develops, and produces innovative biotherapeutics for people with life-threatening disorders. Talecris utilizes MODA's mobile data acquisition platform to automate their quality control (QC) process for improved Environmental Monitoring (EM), Utility Testing, and Product Testing.

Common manual paper-based process steps still burden most QC Micro programs: paper scheduling, sharpie pen labeling of sample media, manual reconciliation, paper log book entry, and manual notification on deviations. These steps are labor-intensive, time consuming, and yield duplication of tasks and high error rates. Talecris' implementation of MODA-EM allows them to achieve the goal of a paperless, automated QC organization.

During this live, 60-minute Webinar, MODA and Talecris will discuss the following:

 
  • Paperless QC Process and MODA-EM
  • Scope of the Talecris QC Micro Program
  • Previous Processes and the Need for Automation
  • Key Requirements for New Solution and Selection Process
  • Implementation and Validation of MODA-EM
  • Current State and Plans for the Future

The Webinar is co-sponsored by heipha and Biotest.

To learn more and register, visit http://www.modatp.com/index.php/interactive-webinars

About MODA
More science. Less paper. MODA Technology Partners provides a mobile data acquisition platform that enables quality assurance and quality control organizations to automate their regulated manufacturing processes, including pharmaceuticals and consumer products. MODA's flagship software, MODA-EM™, is a paperless QC Micro solution that leverages mobile computing technology and advanced visualization tools for increased operational efficiency, improved quality, and reduced costs. MODA enables companies to advance their Green Initiatives by reducing and eventually eliminating the need for paper-based, labor-intensive environment monitoring programs. MODA is headquartered in Wayne, Pennsylvania, with office locations throughout North America and Europe. For more information, visit http://www.modatp.com.

About heipha and Biotest
heipha Dr. Müller GmbH is a member of the Biotest Group, a company that researches, develops, and manufactures pharmaceutical, biotherapeutic, and microbiology diagnostic products and has specialized in the areas of application of immunology and hematology. For nearly 40 years, heipha has been a leading manufacturer of high-quality culture media for microbial diagnostics, environmental monitoring, and sterility testing. It offers more than 600 different products used in the medical and pharmaceutical fields. heipha is based in Eppelheim (Heidelberg), Germany. For more information, visit http://www.heipha.com. Biotest is based in Dreieich (Frankfurt), Germany. For more information, visit http://www.biotest.com.

###

Read the full story at http://www.prweb.com/releases/2010/04/prweb3895284.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Zeus Webinar: Bioabsorbable Polymers as Biomaterials
2. MODA Offers Paperless QC Micro Webinar Series on Automating Environmental Monitoring, Utility and Product Testing
3. ImClone Systems and Lonza Walkersville to Discuss Paperless QC Micro at PDA Annual Meeting
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
6. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
7. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
8. Microfluidic chambers advance the science of growing neurons
9. Quick microchip test for dangerous antibiotic resistant bacteria
10. GenoLogics Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform
11. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... ... February 04, 2016 , ... Shimadzu Scientific Instruments will ... live demos and poster sessions, and present on the analysis of mycotoxins and ... March 6 to 10 at the Georgia World Congress Center in Atlanta, Georgia. ...
(Date:2/4/2016)... PARK, Calif. , Feb. 4, 2016   DelMar ... biopharmaceutical company focused on the development and commercialization of new ... 18 th Annual BIO CEO & Investor Conference ... in New York, NY . ... an update on the ongoing clinical trial of VAL-083 ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... China , today announced that the ... February 4, 2016 a preliminary non-binding proposal letter, dated ... V-Ming ( Shanghai ) Investment Holdings Co., ... Shenzhen ) Fund Management Co., Ltd., Beijing ...
(Date:2/3/2016)... SAN DIEGO , Feb. 3, 2016 /PRNewswire/ ... medicine company with the first pluripotent stem cell-derived ... 1 diabetes in clinical-stage development, today announced that ... Janssen Pharmaceutical Companies of Johnson & Johnson, have ... BetaLogics group into ViaCyte.  The agreement provides ViaCyte ...
Breaking Biology Technology:
(Date:1/8/2016)... , January 8, 2016 NXTD ... and WorldVentures ® , a privately held leading direct ... Inc. 5000 fastest-growing company announced that on ... of $2 million in Nxt-ID to develop a proprietary ... Nxt-ID,s Wocket ® , a unique smart wallet that ...
(Date:1/7/2016)... 7, 2016 Various factors have contributed ... such as biologics and biosimilars. Some of these ... expenditure, growing demand for cost-effective alternatives, growing burden ... are similar versions of their corresponding patented biologic ... quality, safety, and efficacy. The global biosimilars market ...
(Date:1/6/2016)... 6, 2016  Varam Capital, a provider of micro-finance ... to deliver advanced authentication solutions to their clients. Varam ... poor. A loan of a few thousand rupees may ... the ability to purchase livestock or equipment for a ... stock for a local store. ...
Breaking Biology News(10 mins):